Allison Voisin, Maud Plaschka, Marlène Perrin-Niquet, Julie Twardowski, Insaf Boutemine, et al.. The NF-κB RelA transcription factor is not required for CD8+ T-cell function in acute viral infection and cancer. Frontiers in Immunology, 2024, 15, pp.1379777. ⟨10.3389/fimmu.2024.1379777⟩. ⟨hal-04526553⟩

Armelle Dufresne, Valéry Attignon, Anthony Ferrari, Laurie Tonon, Sandrine Boyault, et al.. Added value of whole‐exome and RNA sequencing in advanced and refractory cancer patients with no molecular‐based treatment recommendation based on a 90‐gene panel. Cancer Medicine, 2024, 13 (7), pp.e7115. ⟨10.1002/cam4.7115⟩. ⟨hal-04646005⟩

Anthony Di Roio, Margaux Hubert, Laurie Besson, Marion Bossennec, Céline Rodriguez, et al.. MDR1-expressing CD4⁺T cells with Th1.17 features resist to neoadjuvant chemotherapy and are associated with breast cancer clinical response. Journal for Immunotherapy of Cancer, 2023, 11 (11), ⟨10.1136/jitc-2023-007733⟩. ⟨hal-04379561⟩

Olivier Trédan, Maud Toulmonde, Christophe Le Tourneau, Laure Montane, Antoine Italiano, et al.. Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort. Cancers, 2023, 15, ⟨10.3390/cancers15133441⟩. ⟨hal-04209734⟩

Philippe Cassier, Raul Navaridas, Melanie Bellina, Nicolas Rama, Benjamin Ducarouge, et al.. Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer. Nature, 2023, 620, pp.409 - 416. ⟨10.1038/s41586-023-06367-z⟩. ⟨hal-04184294⟩

Adrien Bertrand-Chapel, Cassandre Caligaris, Tanguy Fenouil, Clara Savary, Sophie Aires, et al.. SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4. Communications Biology, 2022, 5 (1), pp.1068. ⟨10.1038/s42003-022-03994-6⟩. ⟨hal-03915470⟩